FDA Adverse Event Injury Summary report: N

ADVANTAGE FIT SYSTEM

MDR report key: 15995047 · Received December 16, 2022

Report

Report Number
3005099803-2022-07461
Event Type
Injury
Date Received
December 16, 2022
Date of Event
August 23, 2017
Report Date
December 16, 2022
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OTN
UDI-DI
08714729784777
PMA / PMN Number
K020110
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT IS APPROXIMATED TO (B)(6) 2017, FIRST REVISION DATE, AS NO EVENT DATE WAS REPORTED. THIS EVENT WAS REPORTED BY THE PATIENT'S LEGAL REPRESENTATION. THE IMPLANTING AND REVISION SURGEON IS (B)(6). (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ADVANTAGE FIT SYSTEM WAS USED DURING AN ANTERIOR AND POSTERIOR REPAIR, SACROSPINOUS HYSTEROPEXY, MID-URETHRAL SLING AND CYSTOSCOPY PROCEDURE PERFORMED ON (B)(6) 2017, FOR THE TREATMENT OF RECURRENT PROLAPSE AND STRESS URINARY INCONTINENCE. FINDING OF THE PROCEDURE INCLUDES ABSENCE OF LABIA MINORA AND MAJORA CONSISTENT WITH RADICAL VULVECTOMY. ON(B)(6) 2017, THE PATIENT UNDERWENT SLING LOOSENING AND CYSTOSCOPY WITH BLADDER BIOPSY WITH INDICATION OF OBSTRUCTED VOIDING AND TRIGONE LESION REMOVAL.. A GENTAMICIN WAS GIVEN INTRA-OPERATION DUE TO URINARY TRACT INFECTION. ON (B)(6) 2018, PATIENT UNDERWENT SLING DIVISION AND PARTIAL EXCISION AND CYSTOSCOPY WITH URETHRAL DILATION DUE TO URINARY OBSTRUCTION POST MID-URETHRA SLING AND SEVERE OVERACTIVE BLADDER. ON (B)(6) 2018, PATIENT UNDERWENT FLUOROSCOPIC PLACEMENT OF S3 LEAD FOR STAGE 1 SACRAL NEUROMODULATION. OPERATIVE FINDING INCLUDES OVERACTIVE BLADDER AND FECAL INCONTINENCE. ON (B)(6) 2018, THE PATIENT UNDERWENT IMPLANTATION OF PULSE GENERATOR FROM AN UNKNOWN MANUFACTURER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1484329 ADVANTAGE FIT SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR OTN BOSTON SCIENTIFIC CORPORATION M0068502110 0000060408 08714729784777

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female Required Intervention